Advertisement

Interaction between Neutrophils and Mediators of Inflammation

  • S. Spisani
  • E. Vicenzi
  • S. Traniello
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 141)

Abstract

In an inflammatory reaction three basic components are recognized: Injury to tissues, inflammatory mediators and tissue responses. Trauma causes tissue injury, this leads to the appearance of local inflammatory mediators which induce the tissue reactions, responsible in turn for the inflammatory symptoms.

Keywords

Human Neutrophil Chemotactic Response Leukocyte Chemotaxis Chemotaxis Chamber Granule Enzyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S.H. Ferreira, Prostaglandins, in: ‘Chemical messen-gers of the inflammatory process“, J.C. Houck, ed.,Elsevier/North-Holland Biomedical Press, Amsterdam (1979).Google Scholar
  2. 2.
    P.C. Wilkinson, “Chemotaxis and inflammation”,ChurchillLivingstone, Edinburgh (1974).Google Scholar
  3. 3.
    S. Spisani and S. Traniello, Effect of mediators of inflammation on human neutrophil motility, in: “Advan-ces in inflammation research”, Vol. 1, G. Weissmann,B. Samuelsson, R. Paoletti, eds., Raven Press, New York (1979).Google Scholar
  4. 4.
    D. Rigal, J.C. Monier and S. Souweine, The effect of histamine on leukocyte migration test in man, Cell. Immunol. 46: 360 (1979).Google Scholar
  5. 5.
    F.H. Valone and E.J. Goetzl, Immunologic release in the rat peritoneal cavity of lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes, J. Immunol. 120: 102, (1978).PubMedGoogle Scholar
  6. 6.
    E.J. Goetzl and R.R. Gorman, Chemotactic and chemoki netic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10heptadecatrienoic acid (HHT), J. Immunol 120: 526 (1978).PubMedGoogle Scholar
  7. 7.
    I.L. Bonta and M.J. Parnham, prostaglandins and chro nic inflammation, Biochem. Pharmacol. 27: 1611 (1978).Google Scholar
  8. 8.
    G.A. Higgs, E. McCall and L.J.F. Youlten, A chemotac tic role for PGs release from polymorphonuclear leu kocytes during phagocytosis, B. J. Pharmacol. 53: 539 (1975).Google Scholar
  9. 9.
    A.J. Anderson, W.E. Broklehurst and A.L. Willis, Evi dence for the role of lysosomes in the formation of prostaglandins during carrageenin induced inflamma tion in the rat, Pharmacol. Res. Commun. 3: 13 (1971).Google Scholar
  10. 10.
    M. Glatt, B. Peskar and K. Brune, Leukocytes and pro staglandins in acute inflammation, Experientia 30: 1257 (1974).PubMedCrossRefGoogle Scholar
  11. 11.
    S.R. Turner and W.S. Lynn, Lipid molecules as chemo tactic factors, in: “Leukocyte chemotaxis: Methods, physiology and clinical implications”, J.I. Gallin and P.G. Quie, eds., Raven Press, New York (1978).Google Scholar
  12. 12.
    A. Barco, S. Benetti, G.P. Pollini, P.G. Baraldi, D. Simoni and C.B. Vicentini, Synthesis of an 11-deoxy8-aza prostaglandin El intermediate, J. Org. Chem. 44: 1734 (1979).CrossRefGoogle Scholar
  13. 13.
    D. Gordon, M.A. Bray and J. Morley, Control of lymphokine secretion by prostaglandins, Nature 262: 401 (1976).PubMedCrossRefGoogle Scholar
  14. 14.
    P.A. Ward, T.E. Hugli and D.E. Chenoweth, Complement and chemotaxis, in: “Chemical messengers of the inflammatory process”, J.C. Houck, ed., Elsevier/North Holland Biomedical Press, Amsterdam (1979).Google Scholar
  15. 15.
    J.R. Vane, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature, New Biol 231: 232 (1971).Google Scholar
  16. 16.
    J.R. Vane, Prostaglandins in the inflammatory respon se, in: “Inflammation mechanism and control”, I.H. Lepow and P.A. Ward, eds., Academic Press, New York (1972).Google Scholar
  17. 17.
    S. Spisani, G. Vanzini and S. Traniello, Inhibition of human leukocyte locomotion by anti-inflammatory drugs, Experientia 35: 803 (1979).PubMedCrossRefGoogle Scholar
  18. 18.
    G.E. Hatch, W.K. Nichols and H.R. Hill, Cyclic nucleotide changes in human neutrophils induced by the moattractants and chemotactic modulators, J. Immunol. 119: 450 (1977).PubMedGoogle Scholar
  19. 19.
    I. Rivkin, J. Rosenblatt and E.L. Becker, The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils, J. Immunol. 115: 1126 (1975).PubMedGoogle Scholar
  20. 20.
    R. Anderson, A. Glover and A.R. Rabson, The in vitro effects of histamine and metiamide on neutrophil mo tility and their relationship to intracellular cyclic nucleotide levels. J. Immunol 118: 1690 (1977).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • S. Spisani
    • 1
  • E. Vicenzi
    • 1
  • S. Traniello
    • 1
  1. 1.Istituto di Chimica BiologicaUniversità degli Studi di FerraraFerraraItaly

Personalised recommendations